Home Children at risk of diabetes type 1. Treatment with acetyl-L-carnitine plus nicotinamide – Case reports
Article
Licensed
Unlicensed Requires Authentication

Children at risk of diabetes type 1. Treatment with acetyl-L-carnitine plus nicotinamide – Case reports

  • Ivana Cristina Fernandez , María del Carmen Camberos , Gisel Anabel Passicot , Lucía Camila Martucci and Juan Carlos Cresto EMAIL logo
Published/Copyright: June 20, 2012

Abstract

Objectives: The aim was to evaluate the treatment with acetyl-L-carnitine (50 mg/kg/day) and nicotinamide (25 mg/kg/day) in children at risk of type 1 diabetes. This treatment was effective and harmless in experimental type 1 diabetes in mice.

Patients: Nine out of seventy healthy participants of the type 1 diabetes risk study were treated. They were typified for diabetes with HLA-DQB1 and positive autoantibodies. Children with a first peak of insulin response ≤48 µU were randomly distributed in control and treated patients. Children evolution was followed with an intravenous glucose tolerance test. Control children were treated when was another risk parameter was added. During their evolution all children were treated.

Results: Treatment periods differ (range: 120–16 months) because children began treatment at different times. During the treatment 4 patients recovered their parameters and the medication was suspended; 2 patients continued the treatment with favorable evolution. Two children evolved slowly with normal growth and development. One girl became diabetic because she was treated late.

Conclusions: In children at risk, this treatment delays the development or remits the evolution of type 1 diabetes


Corresponding author: Juan Carlos Cresto, MD, PhD, Endocrinology Research Center (CEDIE-CONICET), Htal. de Niños “R. Gutiérrez”, Gallo 1330 (1425), Buenos Aires, Argentina Phone: 054-11-4963-5931 int. 123, Fax: 054-11-4963-5930

Received: 2012-4-19
Accepted: 2012-4-27
Published Online: 2012-06-20
Published in Print: 2013-04-01

©2013 by Walter de Gruyter Berlin Boston

Articles in the same Issue

  1. Masthead
  2. Masthead
  3. Editorial
  4. Premature adrenarche: not always benign?
  5. Review Article
  6. From fat cell biology to public health preventive strategies – pinpointing the critical period for obesity prevention
  7. Images in Pediatric Endocrinology
  8. Pituitary macroadenoma due to hypothyroidism
  9. Parathyroid adenoma presented with multiple brown tumors and nephrocalcinosis
  10. Original Articles
  11. In children with premature adrenarche, bone age advancement by 2 or more years is common and generally benign
  12. Accelerated early pubertal progression, ovarian morphology, and ovarian function in prospectively followed low birth weight (LBW) girls
  13. Long-term secular trend of skeletal maturation of Taiwanese children between agricultural (1960s) and contemporary (after 2000s) generations using the Tanner-Whitehouse 3 (TW3) method
  14. Influence of developmental and hormonal factors on bone health in adolescent females: a cross-sectional study and review of the literature
  15. Predicting growth response among Egyptian prepubertal idiopathic isolated growth hormone deficient children
  16. Egyptian growth hormone deficient patients: demographic, auxological characterization and response to growth hormone therapy
  17. Improved metabolic and cardiorespiratory fitness during a recreational training program in obese children
  18. Mitochondrial uncoupling protein 2 (UCP2) gene polymorphisms are associated with childhood obesity and related metabolic disorders
  19. OGTT results in obese adolescents with normal HOMA-IR values
  20. Type of infectious disease affects glucose metabolism and liver glycogen content in Surinamese children: malaria vs. pneumonia
  21. Cognitive and developmental outcome of conservatively treated children with congenital hyperinsulinism
  22. Protective mechanisms against oxidative stress and angiopathy in young patients with diabetes type 1 (DM1)
  23. Glucose metabolism in obese and lean adolescents with polycystic ovary syndrome
  24. Morbidity characteristics of patients with congenital insensitivity to pain with anhidrosis (CIPA)
  25. Age-related reference values for plasma amino acids in a Spanish population measured by gas chromatography-mass spectrometry
  26. Bupropion can close KATP channel and induce insulin secretion
  27. Children at risk of diabetes type 1. Treatment with acetyl-L-carnitine plus nicotinamide – Case reports
  28. Patient Reports
  29. A boy with prepubertal gynecomastia, hyperprolactinemia, and hypothyroidism
  30. Growth hormone deficiency and central precocious puberty in Klinefelter syndrome: report of a case and review of KIGS database
  31. Parathyroid hormone-independent hypercalcemia in an infant with renal dysplasia: possible role of PTHrP
  32. Bilateral pheochromocytomas in a child who had hemihypertrophy and alteration in the VHL gene
  33. Autoimmune polyglandular syndrome type 1 with reversible dilated cardiomyopathy: complete recovery after correction of hypocalcemia and hypocortisolemia
  34. Zellweger syndrome — a lethal peroxisome biogenesis disorder
  35. First seizure as late presentation of velo-cardio-facial syndrome
  36. A novel mutation in a mother and a son with Aarskog-Scott syndrome
  37. Clinical and genetic characterization of a Chinese patient with triple A syndrome and novel compound heterozygous mutations in the AAAS gene
  38. Pseudohypoaldosteronism presenting with thrombocytosis and bilateral pneumothoraces in an infant
  39. Letter to the Editors
  40. Interferon-γ (IFN-γ) in endometriosis: the conjunction point between the retrograde menstruation theory and the inflammatory hypothesis
  41. Methylmalonic aciduria: newborn screening in mainland China?
  42. Hypophosphatemia in small gestational age extremely low birth weight infants and bone metabolic status parameters
Downloaded on 7.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jpem-2012-0128/html?srsltid=AfmBOoq-1FUoKwp6vYAS3Ea0SxiDARjk_ELswA6PG_XBGoAGIqxcApVR
Scroll to top button